Paul Sagerman, MD

Board-Certified Dermatopathologist
Dr. Sagerman

Dr. Paul Sagerman is board certified in anatomic pathology, dermatopathology, and cytopathology by the American Boards of Dermatology and Pathology. He received his medical degree in 1988 at the Albany Medical College in Albany, NY. Afterward, he completed his anatomic pathology residency at Albert Einstein College of Medicine in Bronx, NY. Dr. Sagerman completed a cytopathology Fellowship in 1993 at the Memorial Sloan-Kettering Cancer Center and a dermatopathology Fellowship in 2003 from New York Hospital/Cornell Medical Center in New York, NY.

Since 2005, Dr. Sagerman has served as the esteemed Medical Director of Pathology at Biomedical Consulting Inc (PBC Lab), an independent anatomic pathology laboratory in Tucson, AZ. He has also held hospital positions in surgical pathology, dermatopathology, and cytopathology and has served as Chief of Anatomic and Surgical Pathology at a major medical center. Additionally, for over 28 years, Dr. Sagerman has voluntarily served in various academic settings as a pathology department instructor, Clinical Assistant Professor of Pathology, and faculty lecturer and researcher in New York and Arizona.

Education

Fellowship Training

Dermatopathology
New York Hospital/Cornell Medical Center
New York, NY

Cytopathology
Memorial Sloan Kettering Cancer Center
New York, NY

Residency Training

Anatomic Pathology
Albert Einstein College of Medicine
Bronx, NY

Medical School

Albany Medical College
Albany, NY

Undergraduate

Union College
Schenectady, NY

Board Certifications

Dermatopathology

The American Board of Pathology and The American Board of Dermatology

Anatomic & Clinical Pathology

The American Board of Pathology

Cytopathology

The American Board of Pathology

Memberships

American Society of Dermatopathology

College of American Pathologists

Tucson Maimonides Society

Tucson Dermatology Society

Research & Publications

Research & Publications
  • Parnes SM, Bennett JA, DeConti, Sagerman P. Accuracy of the subrenal capsule xenograft assay in predicting the clinical growth and chemosensitivity of human squamous head and neck carcinomas. J Surg Oncol; 42(1); 1989 Sep; 21-7.
  • Sagerman P, Neidt G, Choi Y, Hu Y. Detection of human papillomavirus type 16 in vulvar dystrophies. Am J Clin Pathol; 98(3); 1992; 357.
  • Sagerman PM, Relman DA Niroomand F, Niedt GW. Localization of Mycobacterium Avium-Intracellulare within a skin lesion of bacillary angiomatosis in a patient with AIDS. Diagn Mol Pathol; 1(3); 1992; 212-6.
  • Sagerman PM, Kadish AS, Niedt GW. Condyloma accuminatum with superficial spirochetosis simulating condyloma latum. Am J Dermatopathol; 15(2); 1993; 176-9.
  • Sagerman PM, Saigo PE, Cordon-Cardo C. Enhanced detection of bladder cancer in urine cytology with the Lewis X, M344, and 19A211 antigens. ACTA Cytol; 37(5); 1993; 176-9.
  • Sagerman PM, Saigo PE, Cordon-Cardo C. Urinary cytology in the diagnosis of low grade transitional cell tumors and reactive conditions; Morphologic and immunocytochemical aspects. Check Sample; CII; 1993; 93-8.
  • Sagerman PM, Saigo PE, Sheinfeld J, Charitonowics E, Cordon-Cardo C. Enhanced detection of bladder cancer in urine cytology with Lewis X, M344, and 19A211 antigens. ACTA Cytol; 38(4); 1994; 517-23.
  • Blumenfeld W, Sagerman PM. Cytologist presence at radiology-guided FNAS: Is it necessary. ACTA Cytol; 38(5); 1994; 830.
  • Blumenfeld W, Chandhoke D, Sagerman P, Turi GK. Expression of neuroendocrine markers in gastric adenocarcinoma. Mod Pathol; 8(1); 1995; 58A.
  • Blumenfeld W, Sagerman PM. Fine needle aspiration as the initial modality in the cytologic diagnosis of lung cancer. ACTA Cytol; 39(5); 1995; 971.
  • Blumenfeld W, Chandhoke D, Sagerman P, Turi GK. Expression of neuroendocrine markers in gastric adenocarcinomas. Arch Pathol Lab Med; 120; 1996;478-81
  • Sagerman PM, Choi YJ, Hu Y, Niedt GW. Human papillomavirus, vulvar dystrophy, and vulvar carcinoma. Gynecol Oncol; 61; 1996; 328-32
  • Sagerman PM, Siddiqi A, Blumenfeld W, Saigo P. Immunocytochemistry as an aid to cytodiagnosis of breast cancer cells in effusions. ACTA Cytol; 40(5); 1996; 1054.
  • Sagerman PM, Blumenfeld W, Turi G, Garcia A. Tumor typing fine needle aspirates of lung and liver with cytokeratins 7, 20, and 23. ACTA Cytol; 40(5); 1996; 1103
  • Blumenfeld W, Hashmi N, Sagerman P. The effect of different methods of smear preparation on interpretive cytologic features. ACTA Cytol; 40(5); 1996; 1106.
  • Miller LJ, Pruett SW, Losada R, Fruaff A, Sagerman P. Clinical Image. Tophaceous gout of the lumbar spine. J Comput Assist Tomogr; 20(6); 1996; 1004-5.
  • Blumenfeld W, Hashmi N, Sagerman P. Comparison of aspiration, touch and scrape preparations simultaneously obtained from surgically excised specimens. ACTA Cytol; 42(6); 1998; 1414-8.
  • Smith FP, Puerto CD, Sagerman P. Estrogen and progesterone levels in carcinomatous and adjacent non-neoplastic epithelium of the breast. Mod Pathol; 12(1); 2000.
  • Smith FP, Puerto CD, Sagerman P. Relationship of estrogen and progesterone receptor protein levels in carcinomatous and adjacent non-neoplastic epithelium of the breast; a histopathologic and image cytometric study. Breast Cancer Res Treat; 65(3); 2001; 241-7.
  • Stratton SP, et al. A Phase 2a Study of Topical Perillyl Alcohol Cream for Chemoprevention of Skin Cancer. Cancer Prev Res;3(2); 2010; 160-9.
  • Sekulic A, et al. Loss of inositol polyphosphate 5-phosphatase is an early event in development of cutaneous squamous cell carcinoma. Cancer Prev Res 3(10); 2010; 1277-83.
  • Stratton SP, et al. A phase 2a study of topical perilyl alcohol cream for chemoprevention of skin cancer. Cancer Prev Res. 3(2);2010; 160-9.
  • Curiel-Lewandrowski C, et al. Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: evaluation of potential chemopreventive activity. Cancer. 118(23); 2012; 5848-56.
  • Einspahr JG, et al. Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma. Cancer Prev Res. 5(8); 2012; 1072.